Current Edition


Summit Therapeutics says PhaseOut DMD clinical trial did not meet primary endpoint

The AIM-listed pharmaceuticals group said that because of the outcome, it is discontinuing its development of ezutromid and as a result, will be implementing cost …

Continue Reading →

9th Annual Clinical Trials Summit 2018

22nd May 2018, Kohinoor Continental Hotel, Mumbai, India “A critical guide for successfully conducting clinical trials” CONFERENCE INTRODUCTION:- With four-out-of-five clinical trials failing to meet …

Continue Reading →